3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
5
Hematologic Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Weight Cycling
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Substance-Related Disorders
1
Smoldering Multiple Myeloma
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Motor Activity
1
Mental Disorders
1
Insulin Resistance
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Head and Neck Carcinoma
1
Genital Neoplasms, Female
1
Interventions
Cyclophosphamide
61
Rituximab
50
fludarabine
34
Prednisone
33
Doxorubicin
28
Biopsy
26
Vincristine
25
Specimen Handling
22
Magnetic Resonance Spectroscopy
20
Bendamustine Hydrochloride
19
pembrolizumab
16
Lenalidomide
16
obinutuzumab
14
fludarabine phosphate
14
Etoposide
14
venetoclax
13
Tacrolimus
11
Mycophenolic Acid
10
Melphalan
10
Dexamethasone
10
zanubrutinib
9
ibrutinib
9
acalabrutinib
9
Radiotherapy
9
Gemcitabine
9
Cytarabine
9
Busulfan
9
Whole-Body Irradiation
8
Mesna
8
Filgrastim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Behavior Therapy
×
1 year
×
Clear all
No trials found.